Evidence map›Paper›PMID 37622090›Full record

ArticleACS catalysis2022

Engineering Embden-Meyerhof-Parnas Glycolysis to Generate Noncanonical Reducing Power.

Edward King, Youtian Cui, Derek Aspacio, Frances Nicklen, Linyue Zhang, Sarah Maxel, Ray Luo, Justin B Siegel, Erick Aitchison, Han Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS catalysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. EngineeringACS catalysis · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Edward KingDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California 92697-3900, United States.
Youtian CuiGenome Center, University of California, Davis, Davis, California 95616, United States.
Derek AspacioDepartment of Chemical and Biomolecular Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.
Frances NicklenDepartment of Biomedical Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.
Linyue ZhangDepartment of Chemical and Biomolecular Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.
Sarah MaxelDepartment of Chemical and Biomolecular Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.
Ray LuoDepartment of Molecular Biology and Biochemistry, Department of Chemical and Biomolecular Engineering, and Department of Biomedical Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.ORCID 0000-0002-6346-8271
Justin B SiegelDepartment of Chemistry, Genome Center, and Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, California 95616, United States.
Erick AitchisonDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California 92697-3900, United States.
Han LiDepartment of Chemical and Biomolecular Engineering and Department of Biomedical Engineering, University of California, Irvine, Irvine, California 92697-3900, United States.ORCID 0000-0002-6113-6433

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI YOUNG, THOMAS MICHAEL · 1987 to 2021
$50.1M
Enzymatic formation of the hydrocarbon skeletons underlying diterpenoid diversityR01GM076324 · NIGMS · IOWA STATE UNIVERSITY · PI PETERS, REUBEN JOHN · 2006 to 2019
$3.4M
Multi-scaled Modeling of Electrostatic and Polarization Effects in BiomoleculesR35GM130367 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI RAY LUO · 2019 to 2026
$3.0M
Engineering an unnatural redox cofactor (uRedox) system for efficient biosynthesis of medicinesDP2GM137427 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, HAN · 2019 to 2022
$2.4M
NIEHS NIH HHS P42 ES004699NIGMS NIH HHS DP2 GM137427NIGMS NIH HHS R01 GM076324NIGMS NIH HHS R35 GM130367
6 · The paper itself

Abstract

Noncanonical cofactors such as nicotinamide mononucleotide (NMN

Indexed as

computational protein designEmbden–Meyerhof–Parnasglyceraldehyde-3-phosphate dehydrogenaseGlycolysisnicotinamide mononucleotidenoncanonical redox cofactororthogonal pathway engineering

Identifiers

PMID37622090
PMCPMC10449333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.